Jashvik Capital Expands Medtech Portfolio with Investment in Rivarp Medical
Mumbai-Based Private Equity Firm Jashvik Capital Expands Medical Devices Platform
MUMBAI: Jashvik Capital, a private equity firm, announced on Tuesday that it is expanding its medical devices platform by having its portfolio company Futura Medtech invest in Bengaluru-based Rivarp Medical. This marks the third investment through the platform, adding new therapeutic segments to Futura and cementing Jashvik's position as a scaled, multi-category medical devices business with domestic and global reach.
The platform had previously invested in Dolphin Sutures in October 2024 and Suture Planet in July 2025. Jashvik Capital had initially invested in Futura, a Bengaluru-based maker of surgical consumables and devices, in June 2024. According to the company, the medical devices and consumables sector is a large and fast-growing opportunity in India and international markets. Through these acquisitions, the management team at Jashvik Capital intends to drive synergies related to innovation, manufacturing, and sales and distribution channels.
Rivarp Medical, founded in 2016, has developed a portfolio of products across high-growth therapeutic segments. The company has in-house manufacturing capabilities and international regulatory approvals, including EU MDR and US FDA certifications. Rivarp distributes its products across India and international markets through a network of over 100 channel partners. The company's strategic partnership with Futura Medtech provides it with access to capital to invest in innovation and deepen customer engagement.
Comparison of Jashvik Capital's Investments in Medical Devices Platform
| Company | Investment Date | Investment Amount |
|---|---|---|
| Dolphin Sutures | October 2024 | Not Disclosed |
| Suture Planet | July 2025 | Not Disclosed |
| Rivarp Medical | [Not Specified] | Not Disclosed |
Jashvik Capital's investment in Futura in 2024 was valued at $25 million. The capital is being used to build devices and consumables across multiple specialty areas, drive organic and inorganic growth, and expand access to high-quality medical products in India and international markets. India's medical devices sector is witnessing sustained double-digit growth, driven by increasing healthcare penetration, a shift towards domestic manufacturing, and expanding export opportunities.
Over the next two years, Jashvik Capital plans to invest in more businesses to further strengthen its product basket and innovation pipeline and deepen its distribution reach. The company's investment in Rivarp Medical marks its third investment through the platform, solidifying its position as a leading player in the medical devices sector.
Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
Investor Takeaway
Investors should consider the growing medical devices market in India and globally.
More in Market
SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire
Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline
